Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins

[1]  S. Gambhir,et al.  Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. , 2014, The Journal of clinical investigation.

[2]  I. Komuro,et al.  VEGF‐A induces its negative regulator, soluble form of VEGFR‐1, by modulating its alternative splicing , 2013, FEBS letters.

[3]  Santosh A. Khedkar,et al.  Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia , 2011, Circulation.

[4]  G. Tiscia,et al.  Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. , 2010, Thrombosis research.

[5]  M. Margaglione,et al.  Role of Thrombophilia in Adverse Obstetric Outcomes and Their Prevention Using Antithrombotic Therapy , 2009, Seminars in thrombosis and hemostasis.

[6]  A. Gori,et al.  Anti‐inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan‐induced pleurisy , 2009, Journal of cellular and molecular medicine.

[7]  M. Margaglione,et al.  Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  M. Margaglione,et al.  Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta. , 2008, Thrombosis research.

[9]  Definitions of infertility and recurrent pregnancy loss. , 2008, Fertility and sterility.

[10]  E. Triche,et al.  Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. , 2007, International journal of fertility and women's medicine.

[11]  A. Birmingham,et al.  The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology , 2006 .

[12]  Y. Miyagi,et al.  Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis , 2004, Thrombosis and Haemostasis.

[13]  E. Triche,et al.  Does heparin therapy improve pregnancy outcome in patients with thrombophilias? , 2004, Journal of thrombosis and haemostasis : JTH.

[14]  G. C. Price,et al.  Tissue factor and tissue factor pathway inhibitor , 2004, Anaesthesia.

[15]  B. Huppertz,et al.  Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia , 2003, Biology of reproduction.

[16]  K. Alitalo,et al.  Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. , 2002, The American journal of pathology.

[17]  S. Wiegand,et al.  Hemochorial Placentation in the Primate: Expression of Vascular Endothelial Growth Factor, Angiopoietins, and Their Receptors Throughout Pregnancy1 , 2002, Biology of reproduction.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  L. Damico,et al.  Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[20]  A. Many,et al.  Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. , 2001, Hypertension in pregnancy.

[21]  N. Mackman,et al.  Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. , 2000, The Journal of clinical investigation.

[22]  P. Nawroth,et al.  Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Carmeliet,et al.  Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Fedele,et al.  Weight at birth by gestational age in Italy. , 1995, Human reproduction.

[25]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[26]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .